A new test to guide breast cancer treatment planning
Part of Cancer, Skin clinical trials.
This study looks at how a new test (PreciseDx Breast) helps doctors make treatment decisions for people newly diagnosed with invasive breast cancer. You may join if your cancer is ductal or mixed ductal-lobular and you haven't had treatment yet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have invasive breast cancer that is ductal or mixed ductal-lobular.
- You have not had invasive breast cancer in the past.
- You have not received chemotherapy or other treatments before surgery (called neoadjuvant therapy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to predict whether radiation after lumpectomy will help women with DCIS, a very early form of breast cancer. You'll take a test called DCISionRT that looks at your cancer's biology, then you'll be randomly assigned to either get radiation or not, so doctors can learn who really needs it.
This study looks at how genomic tests (which analyze your tumor's genes) are used in routine care for early-stage breast cancer that is hormone-sensitive. It may help doctors understand who really needs chemotherapy in addition to hormone therapy.
This trial uses a special PET/CT scan to find breast cancer cells that have a certain marker (CD73). It may help doctors see the cancer more clearly before you start other treatments.
This study examines tiny particles in your blood from breast cancer cells to better predict which treatments will work best for you. Researchers will collect blood samples and a small tissue sample to understand your cancer's characteristics and help doctors choose more effective therapy.
This study looks at the genes in your cancer to find a treatment that might work better for you. It tests your tumor sample to match you with a drug that targets your cancer's specific weaknesses.
This trial tests whether a special ultrasound measurement can help doctors choose the right chemotherapy plan during treatment for breast cancer. It may help avoid under- or over-treatment by adjusting care based on the ultrasound results.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.